MITOCHONDRIAL RESPIROMETRY IN FROZEN BIOLOGICAL SAMPLES
MITOCHONDRIAL RESPIROMETRY IN FROZEN BIOLOGICAL SAMPLES
批准号:
10011475
负责人:
Orian S Shirihai
金额:
$22.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-20 至 2021-04-30
关键词:
AcademiaAcuteAgingBiocompatible MaterialsBiologicalBiological AssayBiotechnologyCardiovascular systemCellsClientClinicalClinical ResearchCommunitiesComplexDataDevelopmentDiseaseDrug ExposureEconomicsEnvironmentEnvironmental MonitoringEvaluationFeedbackFreezingFutureGenetic ModelsGoalsHourHumanImpairmentIndustryInstructionLegal patentMeasurementMeasuresMetabolicMethodologyMethodsMitochondriaMitochondrial DiseasesMonitorMusOrganizational ModelsOutcomeOxygen ConsumptionPatientsPharmaceutical PreparationsPharmacologic SubstancePhasePlayPopulationPositioning AttributePreparationProceduresProtocols documentationReagentReproducibilityResearchResearch ContractsResearch PersonnelRespirationRespiratory physiologyRunningSamplingServicesShipsSideSiteSwabTechnologyTechnology AssessmentTestingTimeTissue SampleTissuesToxicant exposureToxicologyUnited States Food and Drug Administrationclinical applicationclinical developmentclinical practiceclinically relevantenvironmental toxicologyimprovedminimally invasivenew technologyrespiratorytoxicant
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Impaired mitochondrial respiration plays a key role in metabolic, cardiovascular, and aging-related
diseases. However, mitochondrial respirometry analysis currently requires processing of the living tissue
sample within an hour after being taken from the patient. This requirement makes respirometry analysis largely
unfeasible to standard clinical practice and clinical studies. We invented a new technology to assess maximal
mitochondrial respiratory capacity in previously-frozen biological samples, which thus far been considered
impossible by the scientific community. Side-by-side comparison confirmed that our assay accurately reflects
results measured in fresh samples. Our technology thus overcomes the fundamental limitation of standard
approaches that required living tissue. Moreover, our approach consists of simplified sample preparation which
uses significantly less biological material.
Enspire Bio will further develop this patented Frozen Mitos technology to enable respirometry
measurements for clinical applications and frozen samples, which currently is not available. We will achieve
our goals by Aim 1: Establishing standard protocols for oxygen consumption measurements from frozen tissue
samples derived from human and mouse tissue samples. We will further improve throughput by enabling
measurements of oxygen consumption from tissue homogenate instead of isolated mitochondria. Aim 2:
Establishing proprietary kits and delivering those to five beta testing sites including opinion-leading academic
labs, mitochondrial disease centers and a biotech and pharmaceutical company to test and provide feedback.
To provide frozen sample analysis to clients that have no capacity for wet lab assays, we will develop a CRO-
type service in-house where samples will be shipped to EnspireBio for analysis. Working with a set of pilot
academic, clinical and industry clients will provide feedback to establish procedures and the economics of the
CRO model approach for the frozen tissue respirometry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MITOCHONDRIAL RESPIROMETRY IN FROZEN BIOLOGICAL SAMPLES
-
批准号:10251412
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2021
-
负责人:Orian S Shirihai
-
依托单位:
Role of the heme-related mitochondrial antioxidant ABCB10 in alcoholic liver disease
-
批准号:10201420
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2019
-
负责人:Orian S Shirihai
-
依托单位:
Role of the heme-related mitochondrial antioxidant ABCB10 in alcoholic liver disease
-
批准号:10443585
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2019
-
负责人:Orian S Shirihai
-
依托单位:
Mitochondrial dynamics in beta cell function and dysfunction
-
批准号:7645363
-
项目类别:
-
资助金额:$14.45万
-
财政年份:2007
-
负责人:Orian S Shirihai
-
依托单位:
Mitochondrial dynamics in beta cell function and dysfunction
-
批准号:8012816
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2007
-
负责人:Orian S Shirihai
-
依托单位:
Mitochondrial dynamics in beta cell function and dysfunction
-
批准号:7346916
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2007
-
负责人:Orian S Shirihai
-
依托单位:
Mitochondrial dynamics in beta cell function and dysfunction
-
批准号:7535553
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2007
-
负责人:Orian S Shirihai
-
依托单位:
Mitochondrial dynamics in beta cell function and dysfunction
-
批准号:7212876
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2007
-
负责人:Orian S Shirihai
-
依托单位:
FUNCTIONAL HETEROGENEITY OF MITOCHONDRIA IN AN INDIVIDUAL PANCREATIC BETA CELL
-
批准号:7357321
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2005
-
负责人:Orian S Shirihai
-
依托单位:
Metabolic Profiling of Pancreatic Beta Cells
-
批准号:6879325
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2004
-
负责人:Orian S Shirihai
-
依托单位:
Metabolic Profiling of Pancreatic Beta Cells
-
批准号:6952852
-
项目类别:
-
资助金额:$15.84万
-
财政年份:2004
-
负责人:Orian S Shirihai
-
依托单位:
IRON ACQUISITION IN RETICULOCYTES:MECHANISM
-
批准号:6979999
-
项目类别:
-
资助金额:$1.52万
-
财政年份:2003
-
负责人:Orian S Shirihai
-
依托单位:
SYNERGISTIC AMPLIFICATION OF BETA-AMYLOID AND INFGAMMA*
-
批准号:6980025
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2003
-
负责人:Orian S Shirihai
-
依托单位:
TARGETING, IMPORT, AND DIMERIZATION OF A MAMMALIAN MITO*
-
批准号:6979997
-
项目类别:
-
资助金额:$2.27万
-
财政年份:2003
-
负责人:Orian S Shirihai
-
依托单位:
FUNCTIONAL HETEROGENEITY OF MITOCHONDRIA IN A BETA CELL
-
批准号:6979991
-
项目类别:
-
资助金额:$2.27万
-
财政年份:2003
-
负责人:Orian S Shirihai
-
依托单位:
Erythroid transporter function in hemoglobin synthesis
-
批准号:7152947
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2002
-
负责人:Orian S Shirihai
-
依托单位:
Erythroid transporter function in hemoglobin synthesis
-
批准号:6988523
-
项目类别:
-
资助金额:$27.09万
-
财政年份:2002
-
负责人:Orian S Shirihai
-
依托单位:
Erythroid transporter function in hemoglobin synthesis
-
批准号:6850115
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2002
-
负责人:Orian S Shirihai
-
依托单位:
Erythroid transporter function in hemoglobin synthesis
-
批准号:6687776
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2002
-
负责人:Orian S Shirihai
-
依托单位:
Erythroid transporter function in hemoglobin synthesis
-
批准号:6558665
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2002
-
负责人:Orian S Shirihai
-
依托单位:
海外基金